In addition to facilitating the KO of Palb2, deficiency in both p53 and Palb2 may also mimic tumor settings, as somatic TP53 mutations are common in breast cancer associated with BRCA1/223,24 and PALB225. Here, PALB2 is linked to neoplasm.